SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
Special Session: Clinical Late-Breaking Oral Abstracts
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|
Efficacy and Safety of Weekly Islatravir Plus Lenacapavir in PWH at 24 Weeks: A Phase II Study (ABSTRACT
208)
Amy Colson
Community Resource Initiative
HepB-CpG Vaccine Is Superior to HepB-alum in People With HIV and Prior Vaccine Nonresponse: A5379 (ABSTRACT
209)
Kristen Marks
Weill Cornell Medicine, New York, NY, USA
Efficacy, Safety, and Immunogenicity of H56:IC31 Vaccine for Prevention of Recurrent TB (ABSTRACT
210)
Alvaro Borges
Statens Serum Institut
Efficacy, Safety, and PK of BIC/FTC/TAF in Adults With HIV and Tuberculosis on Rifampicin at Week 24 (ABSTRACT
211)
Anushka Naidoo
Center for the AIDS Programme of Research in South Africa
Long-Acting Injectable CAB/RPV is Superior to Oral ART in PWH With Adherence Challenges: ACTG A5359 (ABSTRACT
212)
Aadia I. Rana
University of Alabama at Birmingham, Birmingham, AL, USA
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
7 of
7
|